Intensive postremission therapy in adults with acute nonlymphocytic leukemia using various dose schedules of ara-C: a progress report from the CALGB. Cancer and Leukemia Group B.
Mayer
R J
RJ
Schiffer
C A
CA
Peterson
B A
BA
Budman
D R
DR
Silver
R T
RT
Rai
K R
KR
Cornwell
G G
GG
Ellison
R R
RR
Maguire
M
M
Berg
D T
DT
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D003561:Cytarabine / Q000008:administration & dosage*; D003630:Daunorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D004341:Drug Evaluation; D006801:Humans; D007938:Leukemia / Q000188:drug therapy*; D008875:Middle Aged; D011379:Prognosis
D003561:Cytarabine; D003630:Daunorubicin